CAR-T Therapy Cures Nearly a Third of Aggressive Lymphoma Patients at 10 Years
Landmark trial shows 38% of relapsed lymphoma patients remain cancer-free a decade after a single CAR-T cell infusion.
4,593 articles in this topic
Landmark trial shows 38% of relapsed lymphoma patients remain cancer-free a decade after a single CAR-T cell infusion.
A Nature study uses AI to identify who's at risk for sudden cardiac arrest, fingering cardiac fibrosis as a key hidden culprit.
Osteopenia silently weakens bones in millions, but targeted lifestyle changes can slow and even partially reverse bone loss.
New research finds excessive sugar-protein modifications in Alzheimer's brains — and reducing them improved memory in mouse models.
Lys Therapeutics secures $27M+ to advance LYS241, a monoclonal antibody targeting brain inflammation and cell death in Parkinson's and stroke.
Cognito's Spectris device increased HDL-like lipid transport proteins in cerebrospinal fluid of mild cognitive impairment patients.
A 100,000-patient study reveals the staggering symptom burden of menopause and the care gaps leaving women undertreated for years.
TrimTech Therapeutics secures $47M to advance targeted protein degradation platforms aimed at clearing toxic aggregates linked to Alzheimer's and Parkinson's.
Noom's free GLP-1 Companion program targets muscle loss, side effects, and habit formation to extend results beyond medication.
AcCELLerated Biologics and Forever Labs join forces to let people store their own stem cells now for potential regenerative treatments later.
The European Innovation Council is offering up to €4M per project to turn aging research into real therapies. Deadline: October 2026.
A new review reframes epigenetic clocks as direct readouts of epigenetic drift, deepening our understanding of biological aging measurement.